About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,252 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,252 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 641-660 of 4,252 trials

CompletedA Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With SchizophreniaThe purpose of this study is to assess the pharmacokinetics (the study of the way a drug enters and leaves the blood and tissues over time) and safety of paliperidone palmitate in…NCT01606254·Ichikawa RecruitingStudy to Evaluate the Safety and Efficacy of Ublituximab in Participants With SchizophreniaThe main objective of this Phase 2 study is to assess the efficacy of ublituximab as measured by Positive and Negative Syndrome Scale (PANSS) total score in participants with…NCT07680946·Little Rock, Arkansas and 1 other CompletedTranscranial Direct Current Stimulation and Effects on Early Auditory Processing in SchizophreniaIndividuals with schizophrenia have difficulties in functioning in the community. No one really knows what factors determine how well patients manage in the real world.NCT03537703·Los Angeles, California

Related Searches

Data from ClinicalTrials.govTerms

Active not recruitingSemaglutide in Comorbid Schizophrenia Spectrum Disorder and ObesityRates of obesity in patients with schizophrenia-spectrum disorder (SSD)s have reached epidemic proportions, with established contributing effects of antipsychotic (AP) medications.NCT05333003·Toronto, Ontario

UnknownCost-effectiveness of Interventions in First-episode PsychosisSchizophrenia has very significant economic consequences. Costs fall on many different parts of society, especially on individuals with schizophrenia and their families.NCT02916303·Santander, Cantabria

CompletedPatient-Centered Medication Adherence Intervention for SchizophreniaEfficacious antipsychotic medication treatments for schizophrenia are available; however , antipsychotic regimens frequently do not achieve their potential because of poor…NCT00144027·No. Little Rock, Arkansas

WithdrawnThe Effect of Repetitive Transcranial Magnetic Stimulation in SchizophreniaRepetitive Transcranial Magnetic Stimulation (rTMS) can modulate neuronal activity and has been shown to improve symptoms in patients with schizophrenia, but the underlying neural…NCT03736291

CompletedThinking Skills for Work in Severe Mental IllnessThe purpose of this study is help people with serious mental illness and receiving vocational rehabilitation get and keep the job they want by improving their thinking skills…NCT01926613·Chicago, Illinois and 1 other

CompletedStudy to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I DisorderThis study will evaluate the effect of ALKS 3831 compared to olanzapine on body weight in young adults with schizophrenia, schizophreniform, or bipolar I disorder who are early in…NCT03187769·Little Rock, Arkansas and 56 others

CompletedEfficacy Study of Panax Ginseng to Boost Antipsychotics Effects in SchizophreniaThe objective of the study is to determine whether Panax Ginseng with multiple interactions with key components of brain signaling pathway, can augment the effects of…NCT00401089·Kingston, Ontario and 3 others

CompletedCBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional OutcomesThe goal of this project is to develop guidelines for the clinical tailoring of Cognitive Behavioral Therapy for Insomnia (CBT-I) for Veterans with psychotic disorders and…NCT02535923·Baltimore, Maryland

CompletedRandomized Controlled Trial (RCT) of a Motivational Decision Support SystemIn this study we will definitively test the decision support system in a randomized controlled trial (RCT) among smokers with severe mental illness (SMI) psychotic disorders.NCT02086162·Chicago, Illinois and 2 others

Not yet recruitingEffect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental IllnessSevere mental illness (SMI), including schizophrenia spectrum disorders and bipolar disorder, is associated with significant impairments in psychosocial functioning, daily life…NCT07879118·Istanbul, Istanbul

CompletedStudy Of Talnetant Versus Placebo And Risperidone In SchizophreniaThis study will evaluate whether talnetant (200mg, 400mg, 600mg) twice a day is effective compared to placebo and risperidone 1-3mg twice a day in treating the positive and…NCT00103727·Little Rock, Arkansas and 21 others

CompletedNon-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a RelapseThis is a prospective, non-interventional, multicentre study designed to collect information about the effectiveness, safety and tolerability of Risperidone ISM in patients…NCT05480046·Aachen and 76 others

CompletedCognition, Functioning and Quality of LifePeople affected by schizophrenia often experience poor concentration, lapses in memory and difficulty with completing tasks; and this set of problems are known as neuro-cognitive…NCT00182442·Hamilton, Ontario

Active not recruitingStudy of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy VolunteersThis study will consist of 2 parts: Part Ⅰ - Single Ascending Dose (SAD) study, Part Ⅱ - Food Effect (FE) studyNCT06105151·Beijing, Beijing Municipality

CompletedA Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With SchizophreniaA study to determine the maximum tolerated dose of an investigational drug in subjects with schizophreniaNCT03627195·Long Beach, California

UnknownCigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With SchizophreniaSmokers with schizophrenia spectrum disorders have high rates of morbidity and mortality from smoking-related diseases compared with the general population and current options for…NCT04452175·Catania

CompletedA Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With SchizophreniaThis study proposes to examine the effect of atomoxetine on quality of life and negative symptoms such as social withdrawal, lack of interest in things, lack of thought content…NCT00222794·Pittsburgh, Pennsylvania

PreviousPage 33 of 213Next